Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 140 participants.

Also called NCT02845531

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02845531
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT02845531. Randomized; no masking; primary purpose treatment. Start 2016-11-29 (actual); primary completion 2030-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death
Acronym
VARIANT ICD
Condition
Angina Pectoris, Variant
Condition
Sudden Cardiac Death
Intervention (Device)
Implantable Cardioverter Defibrillator
Intervention (Drug)
Optimal Medical Therapy
Lead sponsor
Kee-joon Choi (class: other)
Collaborator
CardioVascular Research Foundation, Korea (class: other)

Record details

Record id
cardio:ct-nct02845531
Content hash
5a5faf7e0580c49cc1be45f1cc79c55977a2a83f0e9ddc4e1a14d1b78630e72c